Crowley John F.'s most recent trade in Amicus Therapeutics Inc was a trade of 29,181 Common Stock done at an average price of $13.3 . Disclosure was reported to the exchange on March 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 01 Mar 2024 | 29,181 | 573,478 (0%) | 0% | 13.3 | 389,543 | Common Stock | |
| Amicus Therapeutics Inc | F. Crowley John | Director, Executive Chairman | 15 Feb 2024 | 94,969 | 602,659 (0%) | 0% | 14 | 1,329,566 | Common Stock | |
| Amicus Therapeutics Inc | F. John Crowley | Director, Executive Chairman | 15 Feb 2024 | 31,614 | 697,628 (0%) | 0% | 13.8 | 436,551 | Common Stock | |
| Amicus Therapeutics Inc | John Crowley F. | Director, Executive Chairman | 01 Feb 2024 | 31,614 | 750,838 (0%) | 0% | 12.6 | 398,918 | Common Stock | |
| Amicus Therapeutics Inc | F. John Crowley | Director, Executive Chairman | 01 Feb 2024 | 21,596 | 729,242 (0%) | 0% | 12.7 | 273,621 | Common Stock | |
| Amicus Therapeutics Inc | Crowley John F. | Director, Executive Chairman | 22 Jan 2024 | 55,327 | 782,452 (0%) | 0% | 12.4 | 683,958 | Common Stock | |
| Amicus Therapeutics Inc | Crowley John F. | Director, Executive Chairman | 16 Jan 2024 | 31,614 | 837,779 (0%) | 0% | 12.8 | 404,106 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 09 Jan 2024 | 57,620 | 995,492 (0%) | 0% | 0 | Common Stock | ||
| Amicus Therapeutics Inc | F. John Crowley | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.65 per share. | 09 Jan 2024 | 36,865 | 901,007 (0%) | 0% | 13.6 | 503,207 | Common Stock |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 09 Jan 2024 | 36,865 | 958,627 (0%) | 0% | 13.6 | 503,207 | Common Stock | |
| Amicus Therapeutics Inc | F. John Crowley | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 13.65 per share. | 09 Jan 2024 | 31,614 | 869,393 (0%) | 0% | 13.6 | 431,452 | Common Stock |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 09 Jan 2024 | 31,614 | 927,013 (0%) | 0% | 13.6 | 431,452 | Common Stock | |
| Amicus Therapeutics Inc | F. Crowley John | Director, Executive Chairman | 04 Jan 2024 | 10,659 | 937,872 (0%) | 0% | 13.4 | 143,257 | Common Stock | |
| Amicus Therapeutics Inc | F. Crowley John | Director, Executive Chairman | 02 Jan 2024 | 249,665 | 249,665 | - | - | Stock Options (right to buy) | ||
| Amicus Therapeutics Inc | Crowley John F. | Director, Executive Chairman | 02 Jan 2024 | 144,628 | 1,056,948 (0%) | 0% | 0 | Common Stock | ||
| Amicus Therapeutics Inc | F. Crowley John | Director, Executive Chairman | 02 Jan 2024 | 108,417 | 948,531 (0%) | 0% | 13.5 | 1,466,882 | Common Stock | |
| Amicus Therapeutics Inc | Crowley John F. | Director, Executive Chairman | 15 Dec 2023 | 34,572 | 912,320 (0%) | 0% | 0 | Common Stock | ||
| Amicus Therapeutics Inc | F. Crowley John | Director, Executive Chairman | 15 Dec 2023 | 6,043 | 877,748 (0%) | 0% | 12.7 | 76,516 | Common Stock | |
| Amicus Therapeutics Inc | F. Crowley John | Director, Executive Chairman | 01 Dec 2023 | 6,043 | 883,791 (0%) | 0% | 11.1 | 66,956 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 15 Aug 2023 | 6,044 | 926,097 (0%) | 0% | 13.0 | 78,734 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 01 Aug 2023 | 6,044 | 932,141 (0%) | 0% | 13.4 | 80,716 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 17 Jul 2023 | 6,044 | 938,185 (0%) | 0% | 13.4 | 81,263 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 03 Jul 2023 | 6,044 | 944,229 (0%) | 0% | 12.3 | 74,406 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 15 Jun 2023 | 6,044 | 950,273 (0%) | 0% | 13.0 | 78,814 | Common Stock | |
| Intellia Therapeutics Inc | John F. Crowley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 6,473 | 6,473 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | John F. Crowley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 4,425 | 11,716 (0%) | 0% | 0 | Common Stock | |
| Entrada Therapeutics Inc | John F. Crowley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 01 Jun 2023 | 6,044 | 956,317 (0%) | 0% | 11.4 | 68,657 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 15 May 2023 | 6,044 | 962,361 (0%) | 0% | 11.2 | 67,577 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 01 May 2023 | 6,044 | 968,405 (0%) | 0% | 11.8 | 71,335 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 17 Apr 2023 | 6,044 | 974,449 (0%) | 0% | 11.7 | 70,502 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 03 Apr 2023 | 6,044 | 980,493 (0%) | 0% | 11.2 | 67,787 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 15 Mar 2023 | 6,044 | 986,537 (0%) | 0% | 11.3 | 68,547 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 01 Mar 2023 | 4,107 | 994,518 (0%) | 0% | 13.3 | 54,583 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 01 Mar 2023 | 1,937 | 992,581 (0%) | 0% | 13.7 | 26,510 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 15 Feb 2023 | 6,044 | 998,625 (0%) | 0% | 12.9 | 78,217 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 01 Feb 2023 | 147,316 | 1,004,669 (0%) | 0% | 13.1 | 1,931,342 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 01 Feb 2023 | 83,333 | 1,095,389 (0%) | 0% | 6.1 | 508,331 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 01 Feb 2023 | 83,333 | 0 | - | - | Stock Options (right to buy) | ||
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 01 Feb 2023 | 56,596 | 1,151,985 (0%) | 0% | 5.1 | 290,337 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 01 Feb 2023 | 56,596 | 0 | - | - | Stock Options (right to buy) | ||
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 11 Jan 2023 | 210,088 | 1,095,317 (0%) | 0% | 0 | Common Stock | ||
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 11 Jan 2023 | 83,261 | 1,012,056 (0%) | 0% | 12.0 | 1,000,797 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 09 Jan 2023 | 85,102 | 885,229 (0%) | 0% | 11.4 | 972,954 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 04 Jan 2023 | 10,659 | 970,331 (0%) | 0% | 12.0 | 128,228 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 02 Jan 2023 | 414,025 | 414,025 | - | - | Stock Options (right to buy) | ||
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 02 Jan 2023 | 233,248 | 980,990 (0%) | 0% | 0 | Common Stock | ||
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 02 Jan 2023 | 22,116 | 747,742 (0%) | 0% | 11.9 | 263,844 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 02 Jan 2023 | 21,596 | 769,858 (0%) | 0% | 12.2 | 263,687 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 15 Dec 2022 | 10,468 | 791,454 (0%) | 0% | 12.1 | 127,172 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 01 Dec 2022 | 11,347 | 801,922 (0%) | 0% | 12.2 | 138,473 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 15 Nov 2022 | 10,468 | 813,269 (0%) | 0% | 11.6 | 121,866 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 01 Nov 2022 | 11,346 | 823,737 (0%) | 0% | 10.3 | 117,052 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 17 Oct 2022 | 10,468 | 835,083 (0%) | 0% | 10.9 | 114,148 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 03 Oct 2022 | 11,346 | 845,551 (0%) | 0% | 10.7 | 121,926 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 15 Sep 2022 | 10,468 | 856,897 (0%) | 0% | 10.7 | 111,628 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 01 Sep 2022 | 11,346 | 867,365 (0%) | 0% | 11.3 | 128,162 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 15 Aug 2022 | 10,468 | 878,711 (0%) | 0% | 12.3 | 128,585 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Executive Chairman | 01 Aug 2022 | 11,346 | 889,179 (0%) | 0% | 10.0 | 113,029 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 15 Jul 2022 | 10,468 | 900,525 (0%) | 0% | 10.9 | 113,674 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 01 Jul 2022 | 11,346 | 910,993 (0%) | 0% | 10.8 | 122,337 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 15 Jun 2022 | 10,468 | 922,339 (0%) | 0% | 8.0 | 83,839 | Common Stock | |
| Intellia Therapeutics Inc | John F. Crowley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 7,688 | 7,688 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | John F. Crowley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 5,197 | 7,291 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 03 Jun 2022 | 11,346 | 932,807 (0%) | 0% | 8 | 90,768 | Common Stock | |
| Entrada Therapeutics Inc | John F. Crowley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 23 May 2022 | 21,814 | 944,153 (0%) | 0% | 8.0 | 174,567 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 18 Apr 2022 | 8,254 | 965,967 (0%) | 0% | 8.0 | 66,082 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 18 Apr 2022 | 2,214 | 974,221 (0%) | 0% | 8.0 | 17,794 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 14 Jan 2022 | 438,222 | 438,222 | - | - | Stock Options (right to buy) | ||
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 14 Jan 2022 | 239,099 | 894,230 (0%) | 0% | - | Common Stock | ||
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 14 Jan 2022 | 149,660 | 1,043,890 (0%) | 0% | - | Common Stock | ||
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 14 Jan 2022 | 58,891 | 984,999 (0%) | 0% | 10.5 | 620,122 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 14 Jan 2022 | 8,564 | 976,435 (0%) | 0% | 10.2 | 87,610 | Common Stock | |
| Entrada Therapeutics Inc | John F. Crowley | Director | Purchase of securities on an exchange or from another person at price $ 9.72 per share. | 12 Jan 2022 | 5,000 | 5,000 | - | 9.7 | 48,575 | Common Stock |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 05 Jan 2022 | 63,543 | 655,131 (0%) | 0% | 12.2 | 774,119 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 15 Nov 2021 | 24,935 | 849,461 (0%) | 0% | 4.4 | 109,215 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 15 Nov 2021 | 24,935 | 0 | - | - | Stock Options (right to buy) | ||
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 15 Nov 2021 | 24,935 | 824,526 (0%) | 0% | 11.7 | 292,951 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 01 Nov 2021 | 27,739 | 852,265 (0%) | 0% | 3.8 | 105,963 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 01 Nov 2021 | 27,739 | 0 | - | - | Stock Options (right to buy) | ||
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 01 Nov 2021 | 27,739 | 824,526 (0%) | 0% | 12 | 332,868 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 01 Nov 2021 | 7,819 | 824,526 (0%) | 0% | 10.8 | 84,451 | Common Stock | |
| Entrada Therapeutics Inc | John F. Crowley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 15 Oct 2021 | 22,000 | 832,345 (0%) | 0% | 11.2 | 246,871 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 15 Oct 2021 | 22,000 | 24,935 | - | - | Stock Options (right to buy) | ||
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 15 Oct 2021 | 22,000 | 854,345 (0%) | 0% | 4.4 | 96,360 | Common Stock | |
| Intellia Therapeutics Inc | John F. Crowley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2021 | 2,500 | 25,500 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | John F. Crowley | Director | Sale of securities on an exchange or to another person at price $ 119.55 per share. | 11 Oct 2021 | 2,500 | 2,094 (0%) | 0% | 119.6 | 298,875 | Common Stock |
| Intellia Therapeutics Inc | John F. Crowley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.83 per share. | 11 Oct 2021 | 2,500 | 4,594 (0%) | 0% | 18.8 | 47,075 | Common Stock |
| Intellia Therapeutics Inc | John F. Crowley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2021 | 10,000 | 28,000 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | John F. Crowley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.83 per share. | 05 Oct 2021 | 10,000 | 12,094 (0%) | 0% | 18.8 | 188,300 | Common Stock |
| Intellia Therapeutics Inc | John F. Crowley | Director | Sale of securities on an exchange or to another person at price $ 130.92 per share. | 05 Oct 2021 | 3,759 | 4,140 (0%) | 0% | 130.9 | 492,128 | Common Stock |
| Intellia Therapeutics Inc | John F. Crowley | Director | Sale of securities on an exchange or to another person at price $ 129.88 per share. | 05 Oct 2021 | 2,915 | 7,899 (0%) | 0% | 129.9 | 378,600 | Common Stock |
| Intellia Therapeutics Inc | John F. Crowley | Director | Sale of securities on an exchange or to another person at price $ 131.74 per share. | 05 Oct 2021 | 1,846 | 2,294 (0%) | 0% | 131.7 | 243,192 | Common Stock |
| Intellia Therapeutics Inc | John F. Crowley | Director | Sale of securities on an exchange or to another person at price $ 128.83 per share. | 05 Oct 2021 | 1,280 | 10,814 (0%) | 0% | 128.8 | 164,902 | Common Stock |
| Intellia Therapeutics Inc | John F. Crowley | Director | Sale of securities on an exchange or to another person at price $ 132.84 per share. | 05 Oct 2021 | 200 | 2,094 (0%) | 0% | 132.8 | 26,568 | Common Stock |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 01 Oct 2021 | 7,500 | 832,345 (0%) | 0% | 10 | 75,000 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 15 Sep 2021 | 22,000 | 839,845 (0%) | 0% | 11.1 | 243,828 | Common Stock | |
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 15 Sep 2021 | 22,000 | 46,935 | - | - | Stock Options (right to buy) | ||
| Amicus Therapeutics Inc | John F. Crowley | Director, Chairman & CEO | 15 Sep 2021 | 22,000 | 861,845 (0%) | 0% | 4.4 | 96,360 | Common Stock |